AlphaMaven AlphaMaven

Kivo Health Raises Oversubscribed $10M Series A Led by Allumia Ventures to Scale AI-Powered Care for Seniors With Chronic Lung Disease

Reported by Businesswire
Oct 27, 2026· 1 min read
Save Post LinkedIn Email
Key Takeaways
  • • Kivo Health, a Seattle-based AI-powered virtual care company focused on seniors with chronic disease, announced an oversubscribed $10 million Series A round.
  • • Allumia Ventures led the round, with participation from Corewell Health Ventures, Y Combinator, Heuristic Capital and MassMutual Ventures.
  • • The raise brings Kivo's total funding to more than $16 million, according to the company's announcement.
  • • Proceeds will fund national expansion and development of Kivo's AI-powered care platform.
Summary
Kivo Health, an AI-powered virtual care company that works to change how seniors manage chronic disease, announced an oversubscribed $10 million Series A financing led by Allumia Ventures, according to a Business Wire release datelined Seattle. Corewell Health Ventures, Y Combinator, Heuristic Capital and MassMutual Ventures also participated in the round.

The financing brings Kivo's total funding to more than $16 million. The company said the capital will accelerate its national expansion and the development of its AI-powered care platform.

The primary source available for this story is a brief excerpt of the company's announcement, which describes Kivo as tackling one of the biggest challenges in senior chronic care but does not provide further detail on its clinical outcomes, pricing, or customer base. Readers should treat the figures above as company-reported.

Go deeper than the headline

Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.

Start your free 7-day trial

Sources

1 outlet

AlphaMaven summarised this story from the reporting below. Each link opens the original article.

Businesswire Kivo Health Raises Oversubscribed $10M Series A Led by Allumia Ventures to Scale AI-Powered Care for Seniors With Chronic Lung Disease